Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CCR1 | P32246 | 2/20 | 0.43 |
| ▸ | CCR5 | P51681 | 2/20 | 0.43 |
| ▸ | CCR8 | P51685 | 2/20 | 0.43 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 5/20 | 0.38 |
| ▸ | RAB9A | P51151 | 5/20 | 0.38 |
| ▸ | TP53 | P04637 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29809937 | 1.00 | KDM4E (0.43) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL29985874 | 0.98 | KDM4E (0.42) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL30362597 | 0.79 | KDM4E (0.43) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL4916622 | 0.79 | KDM4E (0.43) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL812421 | 0.79 | KDM4E (0.43) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL9575339 | 0.79 | KDM4E (0.39) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL25222671 | 0.78 | KDM4E (0.42) | KDM4ELMNACCR1CCR5CCR8 | |
| Hydrochloric Acid SCHEMBL28598655 | 0.78 | KDM4E (0.42) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL28632180 | 0.78 | KDM4E (0.42) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL29494142 | 0.78 | KDM4E (0.42) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117776958-A | Aromatic hydrocarbon carboxylic acid meta-position alkylation product and synthesis method thereof | 华南理工大学 | 2024-03-29 | — | — | CN | claimed |
| US-9527066-B2 | Dihydroxybipyridine complexes of ruthenium and iridium for water oxidation and hydrogenation | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2016-12-27 | — | — | US | claimed |
| US-20140219911-A1 | DIHYDROXYBIPYRIDINE COMPLEXES OF RUTHENIUM AND IRIDIUM FOR WATER OXIDATION AND HYDROGENATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2014-08-07 | — | — | US | claimed |
| WO-2013033018-A2 | DIHYDROXYBIPYRIDINE COMPLEXES OF RUTHENIUM AND IRIDIUM FOR WATER OXIDATION AND HYDROGENATION | DREXEL UNIVERSITY (US) | 2013-03-07 | — | — | WO | claimed |
| US-20260082802-A1 | ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT | PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) | 2026-03-19 | — | — | US | disclosed |
| CN-117776958-A | Aromatic hydrocarbon carboxylic acid meta-position alkylation product and synthesis method thereof | 华南理工大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-114904492-B | Polymer composite microsphere for extracting and purifying diquat metabolite in blood plasma, preparation method, kit and extraction method | 浙江哈迈科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-114420633-A | Copper deposition in wafer level packaging of integrated circuits | 麦克德米德乐思公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-110713487-B | Novel heterocyclic aromatic hydrazone derivative, pharmaceutically acceptable salt thereof, preparation method and application thereof | 南京大学 | 2022-02-15 | — | — | CN | disclosed |
| EP-3094325-B1 | HETEROARYLS AND USES THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2021-10-13 | — | — | EP | disclosed |
| CN-111032741-A | Stabilization of noble metal catalysts | 瓦克化学股份公司 | 2020-04-17 | — | — | CN | disclosed |
| CN-110713487-A | Novel heterocyclic aromatic hydrazone derivative, pharmaceutically acceptable salt thereof, preparation method and application thereof | 南京大学 | 2020-01-21 | — | — | CN | disclosed |
| WO-2013033018-A2 | DIHYDROXYBIPYRIDINE COMPLEXES OF RUTHENIUM AND IRIDIUM FOR WATER OXIDATION AND HYDROGENATION | DREXEL UNIVERSITY (US) | 2013-03-07 | — | — | WO | disclosed |
| US-20100298562-A1 | Pyridazine and Pyrrole Compounds, Processes For Obtaining Them and Uses | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2010-11-25 | — | — | US | disclosed |
| US-20090326186-A1 | MESOGEN CONTAINING COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| EP-2069345-A2 | PYRIDAZINE AND PYRROLE COMPOUNDS, PROCESSES FOR OBTAINING THEM AND USES | Centre National de la Recherche Scientifique (CNRS) (FR) | 2009-06-17 | — | — | EP | disclosed |
| WO-2008012440-A2 | PYRIDAZINE AND PYRROLE COMPOUNDS, PROCESSES FOR OBTAINING THEM AND USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2008-01-31 | — | — | WO | disclosed |
| US-6828439-B1 | Compounds, composition, and methods for photodynamic therapy | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. | 2004-12-07 | — | — | US | disclosed |
| US-6261538-B1 | CHLOROMETHYLATED RESIN WITH AMINE PHOSPHONIUM SALTS | CHINA PETROCHEMICAL CORPORATION (CN) | 2001-07-17 | — | — | US | disclosed |
| WO-2000050117-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR PHOTODYNAMIC THERAPY | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 2000-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260082802-A1 | ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT | FLNA, FLNB, CDH1 | KDM4E 1010/4885LMNA 1892/4885CCR1 4767/4885 |
| US-20100298562-A1 | Pyridazine and Pyrrole Compounds, Processes For Obtaining Them and Uses | PPOX, PNPO, PLPBP | KDM4E 2333/4885LMNA 4332/4885CCR1 3696/4885 |
| US-20090326186-A1 | MESOGEN CONTAINING COMPOUNDS | MYOC, BMP2, RARG | KDM4E 4212/4885LMNA 1261/4885CCR1 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.